Fate Therapeutics Inc
FATE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001434316
In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Fate Therapeutics Inc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- −24 vs. Q4 2024
- Shares held
- 96.6M
- −4.79M (−4.7%) vs. Q4 2024
- Total value
- $76.3M
- −$89.6M (−54.0%) vs. Q4 2024
- New holders
- 18
- 40 more added
- Sold out
- 42
- 40 more reduced
3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FATE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 156 | $193.2M |
| Q1 2026 | 158 | $88.9M |
| Q4 2025 | 146 | $70.9M |
| Q3 2025 | 143 | $101.6M |
| Q2 2025 | 139 | $88.9M |
| Q1 2025 | 132 | $76.3M |
| Q4 2024 | 159 | $166.5M |
| Q3 2024 | 164 | $401.6M |
| Q2 2024 | 182 | $401.1M |
| Q1 2024 | 167 | $904.0M |
| Q4 2023 | 159 | $357.2M |
| Q3 2023 | 171 | $202.9M |
| Q2 2023 | 188 | $519.6M |
| Q1 2023 | 182 | $641.6M |
| Q4 2022 | 228 | $1.07B |
| Q3 2022 | 239 | $2.41B |
| Q2 2022 | 233 | $2.70B |
| Q1 2022 | 249 | $3.92B |
| Q4 2021 | 250 | $5.66B |
| Q3 2021 | 266 | $5.67B |
| Q2 2021 | 272 | $8.20B |
| Q1 2021 | 260 | $7.73B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Fate Therapeutics Inc; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sphera Funds Management Ltd. | 397,177 | $313.8K | 0.08% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 411,332 | $325.0K | 0.00% | +234,171+132.2% | Added |
| D. E. Shaw & Co., Inc. | 433,192 | $342.3K | 0.00% | −1,103,441−71.8% | Reduced |
| XTX Topco Ltd | 459,308 | $362.9K | 0.02% | +209,508+83.9% | Added |
| Bruce & Co., Inc. | 550,000 | $434.5K | 0.14% | +200,000+57.1% | Added |
| AQR Capital Management LLC | 585,025 | $462.2K | 0.00% | +437,423+296.4% | Added |
| Integral Health Asset Management, LLC | 700,000 | $553.1K | 0.06% | +100,000+16.7% | Added |
| Charles Schwab Investment Management Inc | 703,825 | $556.1K | 0.00% | −66,455−8.6% | Reduced |
| Two Sigma Advisers, LP | 787,000 | $621.8K | 0.00% | −41,100−5.0% | Reduced |
| Northern Trust Corp | 794,973 | $628.1K | 0.00% | −10,545−1.3% | Reduced |
| Monaco Asset Management SAM | 1,149,708 | $908.4K | 0.46% | +822,037+250.9% | Added |
| Woodline Partners LP | 1,424,167 | $1.13M | 0.01% | +1,382+0.1% | Added |
| UBS Group AG | 1,551,081 | $1.23M | 0.00% | +447,688+40.6% | Added |
| OrbiMed Advisors LLC | 1,680,580 | $1.33M | 0.03% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,867,773 | $1.48M | 0.08% | +11,819+0.6% | Added |
| Citigroup Inc | 1,937,133 | $1.53M | 0.00% | +1,155,244+147.8% | Added |
| State Street Corp | 2,110,065 | $1.67M | 0.00% | −117,230−5.3% | Reduced |
| Jacobs Levy Equity Management, Inc | 2,203,323 | $1.74M | 0.01% | +616,336+38.8% | Added |
| Morgan Stanley | 2,240,058 | $1.77M | 0.00% | −582,125−20.6% | Reduced |
| Geode Capital Management, LLC | 2,269,609 | $1.79M | 0.00% | +42,642+1.9% | Added |
| Goldman Sachs Group Inc | 2,458,974 | $1.94M | 0.00% | −17,440−0.7% | Reduced |
| Acadian Asset Management LLC | 2,473,565 | $1.95M | 0.01% | +999,773+67.8% | Added |
| Vestal Point Capital, LP | 2,515,850 | $1.99M | 0.14% | +50,850+2.1% | Added |
| Dimensional Fund Advisors LP | 2,591,558 | $2.05M | 0.00% | −306,819−10.6% | Reduced |
| Baker Bros. Advisors LP | 3,258,402 | $2.57M | 0.03% | 00.0% | Unchanged |
| Johnson & Johnson | 3,379,064 | $2.67M | 0.78% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,398,283 | $2.68M | 0.00% | +1,728,721+103.5% | Added |
| Citadel Advisors LLC | 4,289,159 | $3.39M | 0.00% | −93,098−2.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 7,794,513 | $6.16M | 0.04% | +7,794,513 | New |
| Vanguard Group Inc | 10,310,453 | $8.15M | 0.00% | −22,580−0.2% | Reduced |
| BlackRock, Inc. | 10,681,779 | $8.44M | 0.00% | −259,803−2.4% | Reduced |
| Redmile Group, LLC | 12,872,946 | $10.2M | 0.96% | 00.0% | Unchanged |
| Bellevue Group AG | 0 | $0 | 0.00% | −4,839,779−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −3,555,871−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −3,049,405−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −1,379,556−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −378,619−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −339,994−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −247,564−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −197,704−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −131,472−100.0% | Sold out |
| Aristides Capital LLC | 0 | $0 | 0.00% | −100,555−100.0% | Sold out |
| Institute for Wealth Management, LLC. | 0 | $0 | 0.00% | −66,886−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −65,510−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −61,220−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −53,585−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −35,360−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −34,295−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −33,094−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −31,682−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −29,173−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −26,533−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −25,580−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −24,636−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −19,279−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −16,641−100.0% | Sold out |
| Rpo LLC | 0 | $0 | 0.00% | −14,222−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,633−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −10,666−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −10,001−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −8,728−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −7,776−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −5,430−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −626−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −437−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −260−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −255−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −237−100.0% | Sold out |
| Caitlin John, LLC | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Shell Asset Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Hilltop National Bank | – | – | – | – | Not filed |
| Legacy Investment Solutions, LLC | – | – | – | – | Not filed |